Brain Stimulation for Cannabis Use in Teens and Young Adults
Part of Mental health clinical trials.
This study tests whether transcranial magnetic stimulation (TMS)—a non-invasive technique that uses magnetic pulses to stimulate the brain—can help reduce cannabis use in people ages 15–21. TMS is already used to treat depression and may help reduce cravings and urges to use cannabis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 15 and 21 years old
- You use cannabis at least 3 days per week (or 12+ days in the past month)
- You want treatment for cannabis use and have been diagnosed with cannabis use disorder
- You are fluent in spoken English
- If under 18, a parent or guardian can consent and you agree to participate; if 18+, you can consent yourself
- You have no serious medical conditions that would make brain stimulation unsafe (like epilepsy, brain tumors, or implanted metal devices)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a treatment called repetitive transcranial magnetic stimulation (a non-surgical magnetic stimulation to the brain) can help people reduce or stop cannabis use. You may be eligible if you have cannabis use disorder and meet specific safety and symptom criteria.
This study tests whether adding a noninvasive brain stimulation technique (called tACS) to motivational interviewing—a type of counseling—can help people reduce their cannabis use. You will receive the brain stimulation during counseling sessions, and your progress will be monitored over several weeks.
This study tests whether a gentle brain stimulation technique (called tDCS) can help people who want to cut down or stop using cannabis. You'll wear a headband-like device during sessions at NYU, and the study team will check in with you over time.
This study tests if a non-invasive brain stimulation technique can help reduce cravings for cannabis in people with schizophrenia. It aims to see if this approach can improve outcomes for those who use cannabis and have a psychotic disorder.
This trial studies whether a noninvasive brain stimulation method (tDCS) can reduce cannabis cravings in people with schizophrenia who use cannabis often. It may help by lowering craving and improving control over cannabis use, but you must meet specific safety and medication-use requirements.
This study looks at the brains of teenagers who use cannabis using an MRI scanner. It aims to understand how cannabis affects the developing brain, which might help improve treatment options.
Hear when a new Cannabis Use trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.